Diazinon


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000067877 Autism Spectrum Disorder PMID:30894343
MESH:D000382 Agricultural Workers' Diseases PMID:11888590; PMID:15496540; PMID:16236997; PMID:16487989; PMID:17327316; PMID:17975796; PMID:18343878; PMID:19289390; PMID:19541724; PMID:20818537; PMID:24064777; PMID:24906048; PMID:25907210
MESH:D001049 Apnea PMID:7893043
MESH:D001249 Asthma PMID:19541724
MESH:D001724 Birth Weight PMID:31675560
MESH:D003072 Cognition Disorders PMID:18096363
MESH:D003866 Depressive Disorder PMID:24906048
MESH:D003920 Diabetes Mellitus PMID:18343878
MESH:D004417 Dyspnea PMID:16487989; PMID:1855619; PMID:31981688
MESH:D005355 Fibrosis PMID:23201499
MESH:D006332 Cardiomegaly PMID:23523949
MESH:D006470 Hemorrhage PMID:23523949
MESH:D006505 Hepatitis PMID:16487989
MESH:D006940 Hyperemia PMID:29383019; PMID:30359674
MESH:D006943 Hyperglycemia PMID:22484362; PMID:23795780; PMID:30359674; PMID:35403302
MESH:D006949 Hyperlipidemias PMID:24132704
MESH:D007022 Hypotension PMID:24392635
MESH:D007035 Hypothermia PMID:21767560
MESH:D007037 Hypothyroidism PMID:24064777
MESH:D007248 Infertility, Male PMID:12948887; PMID:16466525
MESH:D007249 Inflammation PMID:23523949
MESH:D007938 Leukemia PMID:16236997
MESH:D008175 Lung Neoplasms PMID:15496540; PMID:16236997; PMID:25907210
MESH:D008224 Lymphoma, Follicular PMID:25018334; PMID:25337994
MESH:D008569 Memory Disorders PMID:23212306; PMID:35452779
MESH:D008607 Intellectual Disability PMID:30894343
MESH:D009127 Muscle Rigidity PMID:1855619
MESH:D009336 Necrosis PMID:23523949; PMID:27920530
MESH:D009369 Neoplasms PMID:16236997
MESH:D010051 Ovarian Neoplasms PMID:26150671
MESH:D010182 Pancreatic Diseases PMID:22484362
MESH:D010243 Paralysis PMID:34725835
MESH:D010300 Parkinson Disease PMID:19907334; PMID:24057998
MESH:D011041 Poisoning PMID:17603234; PMID:20338157; PMID:22209767; PMID:28728110; PMID:32900191
MESH:D011297 Prenatal Exposure Delayed Effects PMID:31251962; PMID:31704166
MESH:D012220 Rhinitis PMID:19289390; PMID:20818537
MESH:D012640 Seizures PMID:1855619
MESH:D012798 Sialorrhea PMID:31981688
MESH:D014202 Tremor PMID:21767560; PMID:31981688
MESH:D014570 Urologic Diseases PMID:16487989
MESH:D015430 Weight Gain PMID:30359674
MESH:D015431 Weight Loss PMID:20123610; PMID:34725835
MESH:D016640 Diabetes, Gestational PMID:17327316
MESH:D019954 Neurobehavioral Manifestations PMID:35452779
MESH:D029481 Bronchitis, Chronic PMID:17975796
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:22484362; PMID:29383019; PMID:30359674; PMID:35403302
MESH:D059445 Anhedonia PMID:25972795
MESH:D062025 Organophosphate Poisoning PMID:11022865; PMID:1855619; PMID:18796381; PMID:23123253; PMID:31981688

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.